Oct 16, 2018eFFECTOR Therapeutics Announces Clinical Collaboration with Merck to Conduct a Phase 2 Combination TSAN DIEGO, Oct. 16, 2018 /PRNewswire/ -- eFFECTOR Therapeutics, Inc., a leader in the development of selective translation regulators...
Oct 2, 2018FierceBiotech names Gossamer Bio as one of its “Fierce 15” biotech companies of 2018San Diego, CA – October 2, 2018 – Gossamer Bio, Inc. (“Gossamer Bio”) today announced that it has been named by FierceBiotech as one of...